Developer docs
API playgroundTry for free, no card

Search company profiles

mySugr

Full company profile

uuid0006935

Namestring
mySugr
Legal namestring
mySugr GmbH
Websiteurl
mysugr.com
Company typeenum
Private
Founded yearint
2011
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersVienna, Austria
HQ citystring
Vienna
HQ countrystring
Austria
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diabetes management app, mobile health tracking, blood glucose monitoring, continuous glucose monitoring, digital diabetes platform
Industry4 codes
1Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators)
CodeHLAHAHAJPrimaryYes
2Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
CodeHLALAFAAPrimaryNo
3Blood Glucose Monitoring (BGM) Meters & Test Strips
CodeHLAHAHAGPrimaryNo
4Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers)
CodeCRACAQAEPrimaryNo
Product category
Digital Diabetes Management
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model5 records
1Freemium App Model (Basic/PRO)
TypeFreemium
Description

mySugr Logbook basic version is free for Android and iOS. mySugr PRO is offered at no cost when users sync a compatible connected device, or via paid subscription (monthly/annual). Revenue generated from PRO subscriptions, upsells, and premium features.

mysugr.com
2mySugr Bundle (Hardware + Subscription)
TypeHardware Sales
Description

Complete service combining mySugr PRO with blood glucose meter (Accu-Chek) and automatic test strip delivery. Revenue from hardware sales and recurring supply orders triggered by actual measurements.

mysugr.com
3mySugr Bundle (Subscription)
TypeSubscription Recurring
Description

Complete service including mySugr PRO, Bolus Calculator, mySugr Coach, blood glucose meter from partners, and need-based test strip supply. Sold in US by mySugr Inc. with additional terms and conditions.

mysugr.com
4Insurance Reimbursement
TypeSubscription Recurring
Description

Insurance companies (public and private) cover costs of mySugr products for beneficiaries. Billing based on insurance tariff, enabling B2B2C revenue from health insurance partnerships.

mysugr.com
5Coaching Services (mySugr Coach)
TypeSubscription Recurring
Description

Coaching services from certified diabetes educators and dieticians available as an extension of mySugr Pro in some countries, providing additional revenue stream.

openloyalty.io
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure
Pricing details3 tiers
1Basic - Free tier for Android and iOS
ModelFreemiumBilling cadenceMonthly
Notes

Free for Android and iOS. Includes: Personalized Logging, Overview Progress Report, Only CSV Reports, Basic Challenges & Tags, Secure Data Backup.

mysugr.com
2PRO - Premium tier with advanced features
ModelHybridBilling cadenceMonthly
Notes

PRO is free when syncing a compatible connected device (e.g., Accu-Chek glucometer). Otherwise available as paid subscription. Includes all Basic features plus: PDF & Excel Reports, Basal Rate for Pump Users, Meal Photos, Blood Sugar Reminders, Empowering Challenges. Subscription fees displayed in app stores, available monthly or annually.

mysugr.com
3mySugr Bundle - Complete service with hardware
ModelSubscriptionBilling cadenceMonthly
Notes

mySugr Bundle combines PRO subscription with Accu-Chek blood glucose meter and automatic test strip delivery. Test strips are automatically ordered when measurements are logged. Availability and composition constantly expanded.

mysugr.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Brand1 of 5 records shown
1mySugr Logbook
Description

The core diabetes management mobile application for logging blood sugar, meals, activity, insulin, and other therapy data.

mysugr.com
+4 more records
Core offering1 text field

mySugr develops and operates a mobile diabetes management platform (mySugr Logbook/PRO) that lets people with diabetes log blood sugar, meals, activity, and insulin, sync data automatically from connected Bluetooth glucose meters and CGM systems, analyze patterns, and share reports with healthcare providers. The portfolio extends to add-on modules such as a Bolus Calculator and certified diabetes coaching, and is also packaged with Roche/Accu-Chek hardware and recurring test strip delivery as the mySugr Bundle.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • HbA1c reduced from 8.8% to 7.5% (1.3% improvement) in type 2 diabetes patients using Bluetooth glucometer + mySugr app over 3 months
+4 more records
Product overview1 text field

mySugr is a diabetes management platform comprising a mobile app (mySugr Logbook) as the core product, with a free Basic tier and a paid Pro upgrade. The portfolio includes add-on modules such as the mySugr Bolus Calculator (insulin dose calculation) and mySugr Coach (certified diabetes educator support), which are available individually or bundled together with a Roche/Accu-Chek blood glucose meter and automated test strip delivery as the mySugr Bundle. All products are designed for people with diabetes to simplify daily therapy management through logging, device connectivity, data analysis, and reporting.

Product and service5 records
1mySugr Logbook
CategoryDiabetes Management Mobile App
Description

Free mobile application that enables people with diabetes to log and document blood sugar, meals, activity, insulin, and other therapy data, with personalized logging, basic challenges and tags, CSV reports, and secure data backup. Designed for daily diabetes self-management by individuals with Type 1 or Type 2 diabetes.

2mySugr PRO
CategoryPremium App Subscription
Description

Premium paid subscription version of the mySugr Logbook with PDF and Excel reports, basal rate support for insulin pump users, meal photos, blood sugar reminders, and empowering challenges; available via monthly/annual subscription or free upon syncing a compatible connected device.

3mySugr Bolus Calculator
CategoryInsulin Dosing Add-on
Description

Additional module that calculates insulin or carbohydrate doses based on user-entered settings (carbs/insulin ratio, correction factors, basal settings). Available combined with mySugr PRO for insulin-dependent adults aged 18+ using Functional Insulin Therapy.

4mySugr Coach
CategoryDiabetes Coaching Service
Description

Coaching service providing comprehensive information and support from certified diabetes educators and dieticians, available independently of time and location as an extension of mySugr PRO in selected countries.

5mySugr Bundle
CategoryDiabetes Management Bundle (Software + Hardware + Supplies)
Description

Bundled package that combines mySugr PRO, the Bolus Calculator, mySugr Coach, a Roche/Accu-Chek blood glucose meter, and automatic recurring test strip delivery based on actual measurements. Sold in the United States through mySugr Inc., a wholly-owned subsidiary of mySugr GmbH.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-12-08
Description

Bluetooth-enabled glucometer (Accu-Chek Instant) paired with mySugr mobile app validated in clinical study across 29 healthcare centers in India with 111 type 2 diabetes patients. Results showed HbA1c reduction from 8.8% to 7.5% over 3 months. PRO offered free with compatible device sync.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-09-16
Description

Roche received CE Mark approval for integration of its Accu-Chek SmartGuide AI-enabled predictive CGM system with mySugr diabetes management app. Users can view CGM glucose values, predictions, and therapy data in one platform. Night Low Predict feature demonstrated 20% reduction in Level 1 hypoglycaemia and 31% in Level 2. System accuracy MARD of 9.2%.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Insurance companies (public and private) work with mySugr to support persons with diabetes. Costs of mySugr products are paid by insurance company directly or reimbursed under user's tariff. Enables B2B2C revenue model and customer acquisition through insurance channels.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Healthcare providers recommend mySugr to patients. Clinical studies conducted with institutions like those in India (Dr V. Mohan et al study) validate app effectiveness. Reports can be shared directly with healthcare professionals for therapy decisions.

5mySugr Inc. (US Subsidiary)
Strategic tierCoreTypeOthers
Description

mySugr Inc. is a wholly owned subsidiary of mySugr GmbH, organized under Delaware law with principal offices in Encinitas, California. Handles mySugr Bundle sales in the United States with additional terms and conditions.

mysugr.com
6Diabetes Therapy Journal
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Peer-reviewed clinical validation published in Diabetes Therapy journal. Study by Dr V. Mohan et al evaluated Bluetooth glucometer paired with mySugr app, demonstrating HbA1c improvements and app usability (70/100 rating).

timesofindia.indiatimes.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Omada delivers digital chronic-disease management (including diabetes prevention and type 2 diabetes programs) via employer and payer channels, overlapping with mySugr's B2B2C insurance-led distribution model.

TypeDirect peer
Description

Glooko offers a device-agnostic diabetes data management platform that aggregates readings from BGMs, CGMs, and insulin pumps — directly comparable to mySugr's device-agnostic Logbook and pattern-analysis functionality.

TypeBroad incumbent
Description

Dexcom's companion analytics app for its CGM franchise offers logging, pattern detection, and reports to patients and providers — a CGM-vendor-owned counterpart to mySugr's CGM integration.

TypeEmerging player
Description

Virta offers a digitally delivered type 2 diabetes reversal program with coaching and remote monitoring, addressing the same patient population as mySugr through a payer-partnered chronic-care model.

TypeDirect peer
Description

DarioHealth sells a connected glucometer, mobile app, and coaching platform targeting diabetes and other chronic conditions — overlapping directly with mySugr's consumer hardware-plus-software subscription model.

TypeBroad incumbent
Description

LifeScan's OneTouch Reveal ecosystem pairs a Bluetooth BGM with a diabetes logging app for millions of users globally, comparable to mySugr's Accu-Chek Instant integration and pattern analysis.

TypeDirect peer
Description

One Drop combines a consumer diabetes management app with coaching and a connected BGM hardware offering, closely mirroring mySugr's app-plus-Coach-plus-Bundle architecture.

TypeBroad incumbent
Description

Roche's Accu-Chek portfolio of BGMs, CGMs, and connected services is the parent ecosystem within which mySugr operates, providing device-software co-distribution that few peers can replicate.

TypeBroad incumbent
Description

Abbott's LibreView platform aggregates FreeStyle Libre CGM data and produces reports for patients and clinicians, comparable to mySugr's device-data aggregation and reporting functionality.

TypeBroad incumbent
Description

Medtronic's CareLink system provides diabetes data management across its insulin pumps and CGMs, directly comparable to mySugr's device-agnostic integration and clinician-reporting workflow.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

mySugr

Digital Diabetes Managementmysugr.com

mySugr firmographics

Firmographics
Name
mySugr
Legal name
mySugr GmbH
Website
https://mysugr.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

mySugr industry classification

Industry
Product category
Digital Diabetes Management
akta.pro primary industry
Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators) (HLAHAHAJ)
akta.pro secondary industries
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Blood Glucose Monitoring (BGM) Meters & Test Strips (HLAHAHAG), Blood Glucose Monitoring Devices (Consumer CGM & Smart Glucometers) (CRACAQAE)

Keywords

  • Diabetes management app
  • Mobile health tracking
  • Blood glucose monitoring
  • Continuous glucose monitoring
  • Digital diabetes platform

Where mySugr is headquartered

Location

Headquarters

HQ city
Vienna
HQ country
Austria
HQ region
Europe

Offices3 records

Markets served

mySugr business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain, Infrastructure

Revenue model

  1. Freemium App Model (Basic/PRO): mySugr Logbook basic version is free for Android and iOS. mySugr PRO is offered at no cost when users sync a compatible connected device, or via paid subscription (monthly/annual). Revenue generated from PRO subscriptions, upsells, and premium features.
  2. mySugr Bundle (Hardware + Subscription): Complete service combining mySugr PRO with blood glucose meter (Accu-Chek) and automatic test strip delivery. Revenue from hardware sales and recurring supply orders triggered by actual measurements.
  3. mySugr Bundle (Subscription): Complete service including mySugr PRO, Bolus Calculator, mySugr Coach, blood glucose meter from partners, and need-based test strip supply. Sold in US by mySugr Inc. with additional terms and conditions.
  4. Insurance Reimbursement: Insurance companies (public and private) cover costs of mySugr products for beneficiaries. Billing based on insurance tariff, enabling B2B2C revenue from health insurance partnerships.
  5. Coaching Services (mySugr Coach): Coaching services from certified diabetes educators and dieticians available as an extension of mySugr Pro in some countries, providing additional revenue stream.

Pricing tiers

ModelBillingPrice
FreemiumMonthlyBasic - Free tier for Android and iOS
HybridMonthlyPRO - Premium tier with advanced features
SubscriptionMonthlymySugr Bundle - Complete service with hardware

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

mySugr product offering

Product offering

Core offering

mySugr develops and operates a mobile diabetes management platform (mySugr Logbook/PRO) that lets people with diabetes log blood sugar, meals, activity, and insulin, sync data automatically from connected Bluetooth glucose meters and CGM systems, analyze patterns, and share reports with healthcare providers. The portfolio extends to add-on modules such as a Bolus Calculator and certified diabetes coaching, and is also packaged with Roche/Accu-Chek hardware and recurring test strip delivery as the mySugr Bundle.

Product overview

mySugr is a diabetes management platform comprising a mobile app (mySugr Logbook) as the core product, with a free Basic tier and a paid Pro upgrade. The portfolio includes add-on modules such as the mySugr Bolus Calculator (insulin dose calculation) and mySugr Coach (certified diabetes educator support), which are available individually or bundled together with a Roche/Accu-Chek blood glucose meter and automated test strip delivery as the mySugr Bundle. All products are designed for people with diabetes to simplify daily therapy management through logging, device connectivity, data analysis, and reporting.

Differentiator

Problem solved

Functional benefit

Brands

  • mySugr Logbook: The core diabetes management mobile application for logging blood sugar, meals, activity, insulin, and other therapy data.
  • mySugr PRO
  • mySugr Bundle
  • mySugr Coach
  • mySugr Bolus Calculator

Products and services

  • mySugr Logbook Free mobile application that enables people with diabetes to log and document blood sugar, meals, activity, insulin, and other therapy data, with personalized logging, basic challenges and tags, CSV reports, and secure data backup. Designed for daily diabetes self-management by individuals with Type 1 or Type 2 diabetes.
  • mySugr PRO Premium paid subscription version of the mySugr Logbook with PDF and Excel reports, basal rate support for insulin pump users, meal photos, blood sugar reminders, and empowering challenges; available via monthly/annual subscription or free upon syncing a compatible connected device.
  • mySugr Bolus Calculator Additional module that calculates insulin or carbohydrate doses based on user-entered settings (carbs/insulin ratio, correction factors, basal settings). Available combined with mySugr PRO for insulin-dependent adults aged 18+ using Functional Insulin Therapy.
  • mySugr Coach Coaching service providing comprehensive information and support from certified diabetes educators and dieticians, available independently of time and location as an extension of mySugr PRO in selected countries.
  • mySugr Bundle Bundled package that combines mySugr PRO, the Bolus Calculator, mySugr Coach, a Roche/Accu-Chek blood glucose meter, and automatic recurring test strip delivery based on actual measurements. Sold in the United States through mySugr Inc., a wholly-owned subsidiary of mySugr GmbH.

Quantifiable outcome

  • HbA1c reduced from 8.8% to 7.5% (1.3% improvement) in type 2 diabetes patients using Bluetooth glucometer + mySugr app over 3 months
  • +4 more outcomes

Companies that use mySugr

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

mySugr technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

AI capability4 records

Feature9 records

mySugr partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • Roche (Accu-Chek Instant)coreTechnology or Integration · 8 December 2025Bluetooth-enabled glucometer (Accu-Chek Instant) paired with mySugr mobile app validated in clinical study across 29 healthcare centers in India with 111 type 2 diabetes patients. Results showed HbA1c reduction from 8.8% to 7.5% over 3 months. PRO offered free with compatible device sync.
  • Roche (Accu-Chek SmartGuide)coreTechnology or Integration · 16 September 2025Roche received CE Mark approval for integration of its Accu-Chek SmartGuide AI-enabled predictive CGM system with mySugr diabetes management app. Users can view CGM glucose values, predictions, and therapy data in one platform. Night Low Predict feature demonstrated 20% reduction in Level 1 hypoglycaemia and 31% in Level 2. System accuracy MARD of 9.2%.
  • Health Insurance CompaniescoreChannel Partner/ Reseller/ DistributorInsurance companies (public and private) work with mySugr to support persons with diabetes. Costs of mySugr products are paid by insurance company directly or reimbursed under user's tariff. Enables B2B2C revenue model and customer acquisition through insurance channels.
  • Healthcare Providers and Clinical InstitutionscoreStrategic or Co-development PartnerHealthcare providers recommend mySugr to patients. Clinical studies conducted with institutions like those in India (Dr V. Mohan et al study) validate app effectiveness. Reports can be shared directly with healthcare professionals for therapy decisions.
  • mySugr Inc. (US Subsidiary)coreOthersmySugr Inc. is a wholly owned subsidiary of mySugr GmbH, organized under Delaware law with principal offices in Encinitas, California. Handles mySugr Bundle sales in the United States with additional terms and conditions.
  • Diabetes Therapy JournalminorStrategic or Co-development PartnerPeer-reviewed clinical validation published in Diabetes Therapy journal. Study by Dr V. Mohan et al evaluated Bluetooth glucometer paired with mySugr app, demonstrating HbA1c improvements and app usability (70/100 rating).

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

mySugr competitors and assessment

Company assessment

Emerging players

  • Omada Health: Omada delivers digital chronic-disease management (including diabetes prevention and type 2 diabetes programs) via employer and payer channels, overlapping with mySugr's B2B2C insurance-led distribution model.
  • Virta Health: Virta offers a digitally delivered type 2 diabetes reversal program with coaching and remote monitoring, addressing the same patient population as mySugr through a payer-partnered chronic-care model.

Direct peers

  • Glooko: Glooko offers a device-agnostic diabetes data management platform that aggregates readings from BGMs, CGMs, and insulin pumps — directly comparable to mySugr's device-agnostic Logbook and pattern-analysis functionality.
  • DarioHealth: DarioHealth sells a connected glucometer, mobile app, and coaching platform targeting diabetes and other chronic conditions — overlapping directly with mySugr's consumer hardware-plus-software subscription model.
  • One Drop: One Drop combines a consumer diabetes management app with coaching and a connected BGM hardware offering, closely mirroring mySugr's app-plus-Coach-plus-Bundle architecture.

Broad incumbents

  • Dexcom Clarity: Dexcom's companion analytics app for its CGM franchise offers logging, pattern detection, and reports to patients and providers — a CGM-vendor-owned counterpart to mySugr's CGM integration.
  • LifeScan (OneTouch Reveal): LifeScan's OneTouch Reveal ecosystem pairs a Bluetooth BGM with a diabetes logging app for millions of users globally, comparable to mySugr's Accu-Chek Instant integration and pattern analysis.
  • Roche Accu-Chek (broader franchise): Roche's Accu-Chek portfolio of BGMs, CGMs, and connected services is the parent ecosystem within which mySugr operates, providing device-software co-distribution that few peers can replicate.
  • Abbott LibreView: Abbott's LibreView platform aggregates FreeStyle Libre CGM data and produces reports for patients and clinicians, comparable to mySugr's device-data aggregation and reporting functionality.
  • Medtronic CareLink: Medtronic's CareLink system provides diabetes data management across its insulin pumps and CGMs, directly comparable to mySugr's device-agnostic integration and clinician-reporting workflow.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

mySugr social profiles

Digital presence

mySugr compliance and trust

Trust signal

Compliance5 records

mySugr financial estimates

Financial estimate

Revenue estimate

Valuation estimate

mySugr leadership team

Management profile

Number of profiles

Profiles3 records

mySugr funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

mySugr M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about mySugr

What does mySugr do?

mySugr develops and operates a mobile diabetes management platform (mySugr Logbook/PRO) that lets people with diabetes log blood sugar, meals, activity, and insulin, sync data automatically from connected Bluetooth glucose meters and CGM systems, analyze patterns, and share reports with healthcare providers. The portfolio extends to add-on modules such as a Bolus Calculator and certified diabetes coaching, and is also packaged with Roche/Accu-Chek hardware and recurring test strip delivery as the mySugr Bundle.

Is mySugr a public or private company?

mySugr is a private company. It is classified as corporate owned and is currently operating.

When was mySugr founded?

mySugr was founded in 2011. It employs 101 to 250 people.

Where is mySugr based?

mySugr is headquartered in Vienna, Austria, in the Europe region.

How does mySugr make money?

Five revenue lines are on record. Freemium App Model (Basic/PRO) is the primary driver. The others are mySugr Bundle (Hardware + Subscription), mySugr Bundle (Subscription), insurance Reimbursement and coaching Services (mySugr Coach).

Who are mySugr's main competitors?

Emerging players on record are Omada Health and Virta Health. Direct peers are Glooko, DarioHealth and One Drop. Broad incumbents are Dexcom Clarity, LifeScan (OneTouch Reveal), Roche Accu-Chek (broader franchise), Abbott LibreView and Medtronic CareLink.

Does mySugr have an API?

No public API is recorded for mySugr.

What industry is mySugr in?

mySugr's product category is Digital Diabetes Management. Its primary akta.pro industry code is HLAHAHAJ, Diabetes Digital Therapeutics & Dose Decision Support (Bolus Calculators), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BGRThe 3 Best Food Apps For Diabetes Management And Glucose (Blood Sugar) TrackingThree food-tracking apps for diabetes management are reviewed: mySugr, Carb Manager, and SNAQ. mySugr offers trend analysis and CGM sync, Carb Manager supports multiple diets, and SNAQ uses AI for meal logging. Prices range from $39.99 to $60 annually, with money-back guarantees.IntuitionLabsPharmaceutical Mobile App Usage and Engagement StrategiesThis comprehensive industry report examines how pharmaceutical companies leverage mobile apps for patient engagement, adherence support, and marketing under the "beyond the pill" strategy, covering engagement techniques such as gamification, personalization, and wearable integration. The report analyzes case studies including MySugr (Roche), Propeller Health (ResMed), Click Therapeutics, and Medisafe, while addressing key challenges including regulatory hurdles, data privacy concerns, and the commercial viability struggles that led to failures like Pear Therapeutics' bankruptcy in 2023. Future innovations are expected to focus on AI-driven personalization, wearable integration, and digital therapeutics, though reimbursement pathways remain a critical bottleneck for sustainable business models in this space.The Times of IndiaHow bluetooth glucometers enabled diabetes care in IndiaA 2025 study published in Diabetes Therapy by Dr V. Mohan et al evaluated Bluetooth-enabled glucometers (Accu-Chek Instant) paired with the mySugr mobile app across 29 healthcare centers in India, involving 111 people with type 2 diabetes over three months. Results showed average HbA1c levels dropped from 8.8% to 7.5%, with those testing six or more times per week achieving greater reductions (1.5%) compared to less frequent testers (1%), while users rated the app's usability at 70 out of 100. India has over 100 million people living with diabetes, with 76.6% experiencing uncontrolled glucose levels, making connected glucometers an affordable and scalable solution for improved diabetes management.The Times of IndiaBeyond the clinic: How mobile connected technology extends doctor-patient relationshipsA study in India demonstrates that using the mySugr app with Accu-Chek glucose meters significantly improved blood sugar control among diabetic patients, reducing average HbA1c levels from 8.8% to 7.5% over three months. The article highlights how smart devices and health apps are transforming healthcare by enabling real-time data tracking, improving patient adherence, and bridging the gap between clinical appointments. This technological integration allows for more personalized care and proactive health management through telemedicine platforms.OpenloyaltyGamification in healthcare: Business benefits and real-life examples [2025]This article provides a comprehensive overview of gamification in healthcare, examining how game mechanics such as points, badges, challenges, and leaderboards are being integrated into patient care, medical training, and health management to improve engagement, treatment adherence, and clinical outcomes. The global healthcare gamification market, valued at $3.15 billion in 2022, is projected to grow at a CAGR of 22.6% through 2030, driven by increasing adoption of fitness apps, emotional health apps, and digital health platforms. The article profiles leading examples including MySugr, Fitbit, Headspace, Mango Health, dacadoo, Happify, and Nike+ Run Club, and cites research from Deloitte and EY showing that gamified health apps demonstrate 15-20% improvement in health outcomes and up to 50% higher user retention compared to standard methods.The Times of IndiaHow diabetes apps make monitoring blood sugar smarter and simplerRoche Diabetes Care India and Times Internet produced a promotional article highlighting the mySugr app as a digital tool for diabetes management. The content emphasizes the app's integration with Accu-Chek meters and its ability to help users track glucose levels, citing research on improved glycemic control.SuperdialChronic Disease Management AppsThe article provides an overview of chronic disease management apps, detailing their core features such as symptom tracking, medication reminders, and health data analytics for conditions like diabetes and heart disease. It highlights specific market examples including MySugr, HeartWatch, AsthmaMD, COPD Navigator, and CatchMyPain, while discussing future trends involving AI integration and telehealth expansion. The text also outlines significant challenges related to data accuracy, user adoption, interoperability with healthcare systems, and privacy security.The Medical FuturistThe 10 Trends Shaping the Future of PharmaThe article outlines ten emerging trends shaping the pharmaceutical industry, including patient advisory boards, digital health strategies integrated with drugs, and the use of digital pills and AI in drug development. It highlights specific corporate activities such as Roche's acquisition of mySugr and regulatory actions by the FDA against companies like 23andMe. The piece also discusses technological advancements in precision medicine, 3D printed drugs, and virtual reality for pain management.Stock TitanRoche's New CGM System Gets CE Mark, Integrates with mySugr AppRoche received CE mark approval for its Accu-Chek SmartGuide continuous glucose monitoring system integrated with the mySugr app. The AI-enabled predictive CGM is now available in 13 countries, with expansion planned to over 30 countries by year-end. The integration aims to simplify diabetes management by combining predictive CGM data with mySugr's logging and bolus calculator tools.NasdaqRoche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experienceRoche received CE Mark approval for the integration of its Accu-Chek SmartGuide AI-enabled continuous glucose monitoring (CGM) solution with the mySugr diabetes management app, with the combined solution set to launch in the first countries later this year. Real-world evidence presented at the EASD Annual Meeting showed that using the Night Low Predict feature reduced Level 1 hypoglycaemic events by 20% and Level 2 hypoglycaemia by 31%, demonstrating significant clinical effectiveness. The Accu-Chek SmartGuide CGM, which can predict glucose levels up to two hours ahead and overnight for up to seven hours, is currently available in 13 countries with plans to expand to over 30 countries across Europe, Latin America, and Asia-Pacific by year-end.